The expression and functionality of ERα were considered to be key determinants of oestradiol efficacy on metabolic health [17] in terms of the link between its impairment and the increased prevalence of specific features of MetS in male or female human subjects and whole body or muscle-specific knockout rodent models [17, 39, 40]. This evidence concerns the gene ESR1 and metabolic syndrome.